BV6 IAP Antagonist: Precision Apoptosis Induction in Canc...
2025-10-21
BV6, a selective IAP antagonist and potent Smac mimetic, empowers researchers to dissect and modulate apoptosis pathways with high specificity. Its robust effects in cancer radiosensitization, chemotherapeutic sensitization, and disease modeling set it apart for translational and in vivo studies.